Further studies showed that the role of ERM in tumor metastasis might result from a mTORC2-dependent pathway in which mTORC2 is found to modulate the actin cytoskeleton and promote migration and invasiveness through regulating RhoA activity, as is demonstrated previously (Figure 1). Here, RHOA is linked to neoplasm.